Literature DB >> 8888221

Hilar cholangiocarcinomas: T2-weighted spin-echo and gadolinium-enhanced FLASH MR imaging.

J A Guthrie1, J Ward, P J Robinson.   

Abstract

PURPOSE: To investigate the use of magnetic resonance (MR) imaging with dynamic gadopentetate dimeglumine enhancement in hilar cholangiocarcinoma.
MATERIALS AND METHODS: Twenty-four patients (14 men, 10 women; aged 27-78 years; mean age, 51 years) with hilar cholangiocarcinoma underwent T2-weighted spin-echo MR imaging in the axial plane and multisection, breath-hold, fast low-angle shot (FLASH) MR imaging in the coronal oblique plane before and at 30, 60, 90, and 120 seconds after bolus injection of gadopentetate dimeglumine. Morphologic features were recorded, and contrast medium enhancement characteristics and contrast-to-noise ratios were calculated for each sequence.
RESULTS: All the lesions were hyperintense on T2-weighted spin-echo images and hypointense on FLASH images. On dynamic gadolinium-enhanced images, progressive heterogeneous enhancement was seen in all patients. Intrahepatic ductal dilatation was present in every patient. Intraluminal components were seen in 11 patients, lobar atrophy in 12, and segmental portal venous occlusion or stenosis in 13. Satellite lesions were present in four patients, and hilar lymph nodal enlargement in 11. Contrast-to-noise ratios were statistically significantly higher on T2-weighted spin-echo images than on all other images.
CONCLUSION: Hilar cholangiocarcinomas have consistent enhancement and morphologic features that can be demonstrated with dynamic contrast-enhanced MR imaging.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8888221     DOI: 10.1148/radiology.201.2.8888221

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  7 in total

1.  MR imaging and MR cholangiopancreatography in the preoperative evaluation of hilar cholangiocarcinoma: correlation with surgical and pathologic findings.

Authors:  Gabriele Masselli; Riccardo Manfredi; Amorino Vecchioli; Gianfranco Gualdi
Journal:  Eur Radiol       Date:  2008-05-08       Impact factor: 5.315

Review 2.  Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009.

Authors:  Murad Aljiffry; Mark J Walsh; Michele Molinari
Journal:  World J Gastroenterol       Date:  2009-09-14       Impact factor: 5.742

Review 3.  Diagnostic and surgical approaches in hilar cholangiocarcinoma.

Authors:  Gerd Otto
Journal:  Int J Colorectal Dis       Date:  2006-03-31       Impact factor: 2.571

4.  The risk factors and diagnosis of cholangiocarcinoma.

Authors:  Christopher A Wadsworth; Adrian Lim; Simon D Taylor-Robinson; Shahid A Khan
Journal:  Hepatol Int       Date:  2012-11-10       Impact factor: 6.047

Review 5.  Imaging of liver cancer.

Authors:  Ben Ariff; Claire R Lloyd; Sameer Khan; Mohamed Shariff; Andrew V Thillainayagam; Devinder S Bansi; Shahid A Khan; Simon D Taylor-Robinson; Adrian K P Lim
Journal:  World J Gastroenterol       Date:  2009-03-21       Impact factor: 5.742

6.  Magnetic Resonance Imaging of cholangiocarcinoma.

Authors:  Katrina A Vanderveen; Hero K Hussain
Journal:  Cancer Imaging       Date:  2004-04-06       Impact factor: 3.909

7.  Diagnostics of biliary dilatation by means of magnetic resonance cholangiopancreatography.

Authors:  Ewa Szalacha-Tarała; Radosław Ramotowski; Wiesław Guz; Antoni Samojedny; Ewa Dziurzyńska-Białek; Przemysław Jadczak
Journal:  Pol J Radiol       Date:  2014-09-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.